Improved diagnosis and management of one of the most common cancers in men – prostate cancer – could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.
Results of a study now published in the journal Endocrine-Related Cancer have shown that the presence of certain molecules in seminal fluid indicates not only whether a man has prostate cancer, but also the severity of the cancer.
Read more . . .
The Latest on: Prostate cancer biomarkers
[google_news title=”” keyword=”Prostate cancer biomarkers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Prostate cancer biomarkers
- AstraZeneca melds with Fusion in $2B radiopharma buyouton March 18, 2024 at 10:52 pm
The biotech expects to see a 30% to 50% reduction in PSA, a prostate cancer biomarker, in the phase 2 trial. If everything goes to plan, the drug candidate could become the first actinium-PSMA ...
- THE PROSTATE CANCER FOUNDATION ANNOUNCES 2023 CHALLENGE AWARDS TOTALING MORE THAN $21 MILLION FOR PROSTATE CANCER RESEARCHon March 14, 2024 at 6:45 am
The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research.
- Association between Prostate Cancer, Elevated PSA, and Raceon March 14, 2024 at 3:00 am
Compared to White men, Black men have a higher risk of developing prostate cancer. Additionally, Black men have a greater risk than White men of pros | Cancer ...
- Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profilingon March 10, 2024 at 5:01 pm
Cite this: Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profiling - Medscape - Jan 01, 2010. * Studies using microdissected samples. All other studies used grossly ...
- TP53, RB1, PTEN Mutations Linked to Worse Survival in Prostate Canceron March 8, 2024 at 11:13 am
In an interview with Targeted Oncology, Rohan Garje, MD, discussed how mutations such as TP53, RB1, and PTEN impact overall survival in patients with metastatic prostate cancer.
- Prostate Canceron February 17, 2024 at 4:00 pm
A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence. The study aimed to ...
- Prostate cancer biomarker test in clinical trials (IMAGE)on February 8, 2024 at 4:32 am
15 years of painstaking research into prostate cancer has now paid off for UniSA Professor Doug Brooks, with the launch of a new biomarker test in clinical trials. Disclaimer: AAAS and EurekAlert!
- Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profilingon February 2, 2024 at 4:01 pm
Cite this: Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profiling - Medscape - Jan 01, 2010. * Studies using microdissected samples. All other studies used grossly ...
- Prostate Health Newson January 9, 2024 at 4:00 pm
New Prostate Cancer Biomarkers Provide Hope to Millions of Men July 19, 2023 — Three new biomarkers for prostate cancer have been identified to help pinpoint potentially aggressive cases of the ...
- How to get in front of prostate canceron September 7, 2022 at 11:24 am
For example, around 15- 20% of patients with prostate cancer lack the tumour suppressor gene PTEN, which result in disease that is difficult to treat. PTEN serves largely as a biomarker of ...
via Bing News